Timor-Leste
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 4.13 (3.34 - 4.93) | 2019 | Modelled | IHME |
| 4.14 (3.38 - 4.96) | 2018 | Modelled | IHME |
| 4.15 (3.34 - 5.01) | 2017 | Modelled | IHME |
| 4.37 (3.54 - 5.26) | 2016 | Modelled | IHME |
| 4.65 (3.76 - 5.53) | 2015 | Modelled | IHME |
| 4.79 (3.88 - 5.72) | 2014 | Modelled | IHME |
| 4.89 (3.97 - 5.85) | 2013 | Modelled | IHME |
| 4.98 (4.05 - 5.99) | 2012 | Modelled | IHME |
| 5.07 (4.10 - 6.11) | 2011 | Modelled | IHME |
| 5.19 (4.18 - 6.27) | 2010 | Modelled | IHME |
| 5.34 (4.30 - 6.41) | 2009 | Modelled | IHME |
| 5.53 (4.43 - 6.65) | 2008 | Modelled | IHME |
| 5.72 (4.56 - 6.88) | 2007 | Modelled | IHME |
| 5.9 (4.65 - 7.07) | 2006 | Modelled | IHME |
| 6.03 (4.70 - 7.24) | 2005 | Modelled | IHME |
| 6.14 (4.83 - 7.33) | 2004 | Modelled | IHME |
| 6.24 (4.91 - 7.47) | 2003 | Modelled | IHME |
| 6.32 (4.98 - 7.60) | 2002 | Modelled | IHME |
| 6.38 (5.07 - 7.67) | 2001 | Modelled | IHME |
| 6.42 (5.11 - 7.78) | 2000 | Modelled | IHME |
| 6.43 (5.13 - 7.82) | 1999 | Modelled | IHME |
| 6.45 (5.16 - 7.81) | 1998 | Modelled | IHME |
| 6.46 (5.18 - 7.84) | 1997 | Modelled | IHME |
| 6.46 (5.20 - 7.88) | 1996 | Modelled | IHME |
| 6.46 (5.21 - 7.91) | 1995 | Modelled | IHME |
| 6.45 (5.20 - 7.85) | 1994 | Modelled | IHME |
| 6.42 (5.16 - 7.81) | 1993 | Modelled | IHME |
| 6.37 (5.11 - 7.72) | 1992 | Modelled | IHME |
| 6.31 (5.06 - 7.64) | 1991 | Modelled | IHME |
| 6.24 (4.98 - 7.54) | 1990 | Modelled | IHME |
| 2 (1.16 - 3.34) | 2015 | Modelled | WHO |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.35 (1.01 - 1.80) | 2019 | Modelled | IHME |
| 1.36 (1.01 - 1.82) | 2018 | Modelled | IHME |
| 1.38 (1.01 - 1.87) | 2017 | Modelled | IHME |
| 1.43 (1.04 - 1.91) | 2016 | Modelled | IHME |
| 1.49 (1.08 - 1.97) | 2015 | Modelled | IHME |
| 1.51 (1.10 - 1.99) | 2014 | Modelled | IHME |
| 1.52 (1.12 - 2) | 2013 | Modelled | IHME |
| 1.53 (1.12 - 2.02) | 2012 | Modelled | IHME |
| 1.54 (1.14 - 2.05) | 2011 | Modelled | IHME |
| 1.57 (1.15 - 2.08) | 2010 | Modelled | IHME |
| 1.87 (1.38 - 2.49) | 2009 | Modelled | IHME |
| 2.56 (1.88 - 3.39) | 2008 | Modelled | IHME |
| 3.4 (2.47 - 4.48) | 2007 | Modelled | IHME |
| 4.12 (3 - 5.46) | 2006 | Modelled | IHME |
| 4.51 (3.26 - 6.02) | 2005 | Modelled | IHME |
| 4.62 (3.37 - 6.11) | 2004 | Modelled | IHME |
| 4.71 (3.46 - 6.20) | 2003 | Modelled | IHME |
| 4.78 (3.49 - 6.27) | 2002 | Modelled | IHME |
| 4.83 (3.53 - 6.37) | 2001 | Modelled | IHME |
| 4.86 (3.52 - 6.42) | 2000 | Modelled | IHME |
| 4.88 (3.54 - 6.44) | 1999 | Modelled | IHME |
| 4.9 (3.55 - 6.46) | 1998 | Modelled | IHME |
| 4.91 (3.53 - 6.52) | 1997 | Modelled | IHME |
| 4.92 (3.52 - 6.56) | 1996 | Modelled | IHME |
| 4.92 (3.50 - 6.55) | 1995 | Modelled | IHME |
| 4.91 (3.51 - 6.56) | 1994 | Modelled | IHME |
| 4.87 (3.47 - 6.45) | 1993 | Modelled | IHME |
| 4.81 (3.42 - 6.43) | 1992 | Modelled | IHME |
| 4.74 (3.36 - 6.35) | 1991 | Modelled | IHME |
| 4.66 (3.29 - 6.25) | 1990 | Modelled | IHME |
| 0.87 (0.45 - 1.56) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 48,876 (39,019 - 59,035) | 1990 | Modelled | IHME |
| 50,575 (40,516 - 61,262) | 1991 | Modelled | IHME |
| 52,103 (41,805 - 63,121) | 1992 | Modelled | IHME |
| 53,439 (42,977 - 65,057) | 1993 | Modelled | IHME |
| 54,558 (43,959 - 66,378) | 1994 | Modelled | IHME |
| 55,439 (44,678 - 67,847) | 1995 | Modelled | IHME |
| 56,158 (45,177 - 68,498) | 1996 | Modelled | IHME |
| 56,801 (45,570 - 68,994) | 1997 | Modelled | IHME |
| 57,382 (45,949 - 69,521) | 1998 | Modelled | IHME |
| 57,870 (46,181 - 70,353) | 1999 | Modelled | IHME |
| 58,379 (46,471 - 70,817) | 2000 | Modelled | IHME |
| 58,856 (46,743 - 70,743) | 2001 | Modelled | IHME |
| 59,126 (46,623 - 71,054) | 2002 | Modelled | IHME |
| 59,269 (46,694 - 71,000) | 2003 | Modelled | IHME |
| 59,371 (46,746 - 70,895) | 2004 | Modelled | IHME |
| 59,524 (46,381 - 71,432) | 2005 | Modelled | IHME |
| 59,451 (46,884 - 71,284) | 2006 | Modelled | IHME |
| 58,980 (46,991 - 70,902) | 2007 | Modelled | IHME |
| 58,317 (46,782 - 70,134) | 2008 | Modelled | IHME |
| 57,688 (46,393 - 69,212) | 2009 | Modelled | IHME |
| 57,346 (46,228 - 69,318) | 2010 | Modelled | IHME |
| 57,374 (46,382 - 69,163) | 2011 | Modelled | IHME |
| 57,587 (46,781 - 69,245) | 2012 | Modelled | IHME |
| 57,793 (46,894 - 69,160) | 2013 | Modelled | IHME |
| 57,778 (46,788 - 69,069) | 2014 | Modelled | IHME |
| 57,314 (46,338 - 68,179) | 2015 | Modelled | IHME |
| 54,920 (44,513 - 66,127) | 2016 | Modelled | IHME |
| 53,287 (42,877 - 64,300) | 2017 | Modelled | IHME |
| 54,171 (44,170 - 64,897) | 2018 | Modelled | IHME |
| 55,192 (44,547 - 65,828) | 2019 | Modelled | IHME |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 6.12 (3.45 - 9.16) | 2019 | Modelled | IHME |
| 6.18 (3.48 - 9.18) | 2018 | Modelled | IHME |
| 6.33 (3.45 - 9.66) | 2017 | Modelled | IHME |
| 6.95 (3.67 - 10.60) | 2016 | Modelled | IHME |
| 7.45 (3.81 - 11.40) | 2015 | Modelled | IHME |
| 7.43 (3.77 - 11.40) | 2014 | Modelled | IHME |
| 7.38 (3.69 - 11.50) | 2013 | Modelled | IHME |
| 7.32 (3.54 - 11.40) | 2012 | Modelled | IHME |
| 7.14 (3.45 - 11.20) | 2011 | Modelled | IHME |
| 6.8 (3.36 - 10.70) | 2010 | Modelled | IHME |
| 6.7 (3.34 - 10.60) | 2009 | Modelled | IHME |
| 6.54 (3.18 - 10.30) | 2008 | Modelled | IHME |
| 6.71 (3.29 - 10.60) | 2007 | Modelled | IHME |
| 6.73 (3.33 - 10.50) | 2006 | Modelled | IHME |
| 6.84 (3.38 - 10.70) | 2005 | Modelled | IHME |
| 6.77 (3.31 - 10.50) | 2004 | Modelled | IHME |
| 6.96 (3.35 - 10.90) | 2003 | Modelled | IHME |
| 6.87 (3.29 - 10.90) | 2002 | Modelled | IHME |
| 6.93 (3.33 - 10.90) | 2001 | Modelled | IHME |
| 6.97 (3.32 - 10.90) | 2000 | Modelled | IHME |
| 6.9 (3.29 - 10.80) | 1999 | Modelled | IHME |
| 6.89 (3.30 - 10.90) | 1998 | Modelled | IHME |
| 6.74 (3.30 - 10.60) | 1997 | Modelled | IHME |
| 6.91 (3.62 - 10.70) | 1996 | Modelled | IHME |
| 6.98 (3.88 - 10.60) | 1995 | Modelled | IHME |
| 6.97 (4.20 - 10.50) | 1994 | Modelled | IHME |
| 7.04 (4.59 - 10.50) | 1993 | Modelled | IHME |
| 6.99 (4.80 - 10.30) | 1992 | Modelled | IHME |
| 6.91 (4.79 - 10.20) | 1991 | Modelled | IHME |
| 7.02 (4.91 - 10.30) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 82 (46 - 122) | 2019 | Modelled | IHME |
| 81 (46 - 120) | 2018 | Modelled | IHME |
| 81 (44 - 124) | 2017 | Modelled | IHME |
| 87 (46 - 133) | 2016 | Modelled | IHME |
| 92 (47 - 140) | 2015 | Modelled | IHME |
| 90 (46 - 138) | 2014 | Modelled | IHME |
| 87 (44 - 136) | 2013 | Modelled | IHME |
| 85 (41 - 132) | 2012 | Modelled | IHME |
| 81 (39 - 127) | 2011 | Modelled | IHME |
| 75 (37 - 119) | 2010 | Modelled | IHME |
| 72 (36 - 114) | 2009 | Modelled | IHME |
| 69 (34 - 109) | 2008 | Modelled | IHME |
| 69 (34 - 109) | 2007 | Modelled | IHME |
| 68 (34 - 106) | 2006 | Modelled | IHME |
| 68 (33 - 106) | 2005 | Modelled | IHME |
| 66 (32 - 102) | 2004 | Modelled | IHME |
| 66 (32 - 104) | 2003 | Modelled | IHME |
| 64 (31 - 102) | 2002 | Modelled | IHME |
| 64 (31 - 100) | 2001 | Modelled | IHME |
| 63 (30 - 100) | 2000 | Modelled | IHME |
| 62 (30 - 97) | 1999 | Modelled | IHME |
| 61 (29 - 97) | 1998 | Modelled | IHME |
| 59 (29 - 94) | 1997 | Modelled | IHME |
| 60 (31 - 93) | 1996 | Modelled | IHME |
| 60 (33 - 91) | 1995 | Modelled | IHME |
| 59 (36 - 88) | 1994 | Modelled | IHME |
| 59 (38 - 87) | 1993 | Modelled | IHME |
| 57 (39 - 84) | 1992 | Modelled | IHME |
| 55 (38 - 82) | 1991 | Modelled | IHME |
| 55 (38 - 81) | 1990 | Modelled | IHME |
| 58 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 41 (30 - 52) | 2019 | Modelled | IHME |
| 41 (30 - 52) | 2018 | Modelled | IHME |
| 41 (30 - 52) | 2017 | Modelled | IHME |
| 42 (31 - 53) | 2016 | Modelled | IHME |
| 43 (32 - 54) | 2015 | Modelled | IHME |
| 43 (32 - 54) | 2014 | Modelled | IHME |
| 43 (32 - 54) | 2013 | Modelled | IHME |
| 43 (32 - 54) | 2012 | Modelled | IHME |
| 43 (32 - 54) | 2011 | Modelled | IHME |
| 43 (32 - 54) | 2010 | Modelled | IHME |
| 43 (32 - 54) | 2009 | Modelled | IHME |
| 43 (32 - 54) | 2008 | Modelled | IHME |
| 44 (33 - 55) | 2007 | Modelled | IHME |
| 44 (33 - 55) | 2006 | Modelled | IHME |
| 45 (33 - 56) | 2005 | Modelled | IHME |
| 45 (33 - 56) | 2004 | Modelled | IHME |
| 46 (34 - 57) | 2003 | Modelled | IHME |
| 46 (34 - 57) | 2002 | Modelled | IHME |
| 46 (34 - 57) | 2001 | Modelled | IHME |
| 46 (34 - 57) | 2000 | Modelled | IHME |
| 46 (34 - 57) | 1999 | Modelled | IHME |
| 47 (35 - 58) | 1998 | Modelled | IHME |
| 47 (36 - 58) | 1997 | Modelled | IHME |
| 47 (36 - 58) | 1996 | Modelled | IHME |
| 48 (37 - 59) | 1995 | Modelled | IHME |
| 48 (38 - 59) | 1994 | Modelled | IHME |
| 48 (39 - 59) | 1993 | Modelled | IHME |
| 48 (39 - 59) | 1992 | Modelled | IHME |
| 48 (39 - 59) | 1991 | Modelled | IHME |
| 49 (39 - 59) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of HepB birth dose
Newborns
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 66 | 2018 | Survey/reported | WHO/UNICEF |
| 61 | 2017 | Survey/reported | WHO/UNICEF |
| 42 | 2016 | Survey/reported | WHO/UNICEF |
| 70 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 83 | 2018 | Survey/reported | WHO/UNICEF |
| 83 | 2017 | Survey/reported | WHO/UNICEF |
| 79 | 2016 | Survey/reported | WHO/UNICEF |
| 76 | 2015 | Survey/reported | WHO/UNICEF |
| 77 | 2014 | Survey/reported | WHO/UNICEF |
| 82 | 2013 | Survey/reported | WHO/UNICEF |
| 83 | 2012 | Survey/reported | WHO/UNICEF |
| 67 | 2011 | Survey/reported | WHO/UNICEF |
| 72 | 2010 | Survey/reported | WHO/UNICEF |
| 72 | 2009 | Survey/reported | WHO/UNICEF |
| 79 | 2008 | Survey/reported | WHO/UNICEF |
| 83 | 2019 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2014 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.45 (1.15 - 1.78) | 2019 | Modelled | IHME |
| 1.45 (1.16 - 1.80) | 2018 | Modelled | IHME |
| 1.44 (1.15 - 1.81) | 2017 | Modelled | IHME |
| 1.43 (1.14 - 1.77) | 2016 | Modelled | IHME |
| 1.41 (1.12 - 1.74) | 2015 | Modelled | IHME |
| 1.41 (1.13 - 1.74) | 2014 | Modelled | IHME |
| 1.42 (1.13 - 1.75) | 2013 | Modelled | IHME |
| 1.42 (1.13 - 1.76) | 2012 | Modelled | IHME |
| 1.43 (1.14 - 1.78) | 2011 | Modelled | IHME |
| 1.44 (1.14 - 1.81) | 2010 | Modelled | IHME |
| 1.45 (1.15 - 1.82) | 2009 | Modelled | IHME |
| 1.48 (1.17 - 1.86) | 2008 | Modelled | IHME |
| 1.51 (1.19 - 1.89) | 2007 | Modelled | IHME |
| 1.54 (1.21 - 1.92) | 2006 | Modelled | IHME |
| 1.57 (1.24 - 1.96) | 2005 | Modelled | IHME |
| 1.61 (1.27 - 2) | 2004 | Modelled | IHME |
| 1.65 (1.32 - 2.06) | 2003 | Modelled | IHME |
| 1.7 (1.35 - 2.13) | 2002 | Modelled | IHME |
| 1.74 (1.39 - 2.16) | 2001 | Modelled | IHME |
| 1.77 (1.41 - 2.21) | 2000 | Modelled | IHME |
| 1.78 (1.42 - 2.22) | 1999 | Modelled | IHME |
| 1.79 (1.43 - 2.24) | 1998 | Modelled | IHME |
| 1.8 (1.44 - 2.25) | 1997 | Modelled | IHME |
| 1.81 (1.44 - 2.25) | 1996 | Modelled | IHME |
| 1.82 (1.44 - 2.27) | 1995 | Modelled | IHME |
| 1.83 (1.45 - 2.29) | 1994 | Modelled | IHME |
| 1.84 (1.46 - 2.30) | 1993 | Modelled | IHME |
| 1.85 (1.47 - 2.31) | 1992 | Modelled | IHME |
| 1.86 (1.47 - 2.32) | 1991 | Modelled | IHME |
| 1.87 (1.48 - 2.34) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 14,621 (11,554 - 18,297) | 1990 | Modelled | IHME |
| 14,884 (11,798 - 18,596) | 1991 | Modelled | IHME |
| 15,105 (12,019 - 18,859) | 1992 | Modelled | IHME |
| 15,292 (12,173 - 19,124) | 1993 | Modelled | IHME |
| 15,449 (12,304 - 19,339) | 1994 | Modelled | IHME |
| 15,582 (12,331 - 19,491) | 1995 | Modelled | IHME |
| 15,709 (12,526 - 19,582) | 1996 | Modelled | IHME |
| 15,832 (12,638 - 19,779) | 1997 | Modelled | IHME |
| 15,942 (12,708 - 19,905) | 1998 | Modelled | IHME |
| 16,017 (12,754 - 19,975) | 1999 | Modelled | IHME |
| 16,072 (12,865 - 20,059) | 2000 | Modelled | IHME |
| 16,052 (12,792 - 19,960) | 2001 | Modelled | IHME |
| 15,912 (12,674 - 19,921) | 2002 | Modelled | IHME |
| 15,720 (12,500 - 19,565) | 2003 | Modelled | IHME |
| 15,552 (12,330 - 19,393) | 2004 | Modelled | IHME |
| 15,488 (12,219 - 19,325) | 2005 | Modelled | IHME |
| 15,500 (12,238 - 19,319) | 2006 | Modelled | IHME |
| 15,526 (12,255 - 19,442) | 2007 | Modelled | IHME |
| 15,589 (12,303 - 19,608) | 2008 | Modelled | IHME |
| 15,716 (12,412 - 19,648) | 2009 | Modelled | IHME |
| 15,933 (12,593 - 19,979) | 2010 | Modelled | IHME |
| 16,203 (12,845 - 20,134) | 2011 | Modelled | IHME |
| 16,477 (13,103 - 20,376) | 2012 | Modelled | IHME |
| 16,765 (13,370 - 20,659) | 2013 | Modelled | IHME |
| 17,074 (13,597 - 21,000) | 2014 | Modelled | IHME |
| 17,413 (13,812 - 21,429) | 2015 | Modelled | IHME |
| 17,964 (14,360 - 22,274) | 2016 | Modelled | IHME |
| 18,537 (14,773 - 23,178) | 2017 | Modelled | IHME |
| 18,931 (15,129 - 23,545) | 2018 | Modelled | IHME |
| 19,305 (15,400 - 23,781) | 2019 | Modelled | IHME |
Showing out of
Show more
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 5.57 (3.19 - 8.47) | 2019 | Modelled | IHME |
| 5.54 (3.17 - 8.44) | 2018 | Modelled | IHME |
| 5.45 (3.13 - 8.28) | 2017 | Modelled | IHME |
| 5.14 (2.92 - 7.87) | 2016 | Modelled | IHME |
| 4.91 (2.81 - 7.57) | 2015 | Modelled | IHME |
| 4.87 (2.70 - 7.57) | 2014 | Modelled | IHME |
| 4.84 (2.63 - 7.71) | 2013 | Modelled | IHME |
| 4.8 (2.58 - 7.67) | 2012 | Modelled | IHME |
| 4.69 (2.44 - 7.61) | 2011 | Modelled | IHME |
| 4.47 (2.34 - 7.34) | 2010 | Modelled | IHME |
| 4.37 (2.28 - 7.17) | 2009 | Modelled | IHME |
| 4.24 (2.22 - 6.90) | 2008 | Modelled | IHME |
| 4.29 (2.27 - 6.97) | 2007 | Modelled | IHME |
| 4.26 (2.25 - 6.89) | 2006 | Modelled | IHME |
| 4.3 (2.29 - 6.89) | 2005 | Modelled | IHME |
| 4.25 (2.21 - 6.81) | 2004 | Modelled | IHME |
| 4.34 (2.21 - 6.88) | 2003 | Modelled | IHME |
| 4.29 (2.15 - 6.91) | 2002 | Modelled | IHME |
| 4.31 (2.18 - 6.92) | 2001 | Modelled | IHME |
| 4.33 (2.21 - 6.96) | 2000 | Modelled | IHME |
| 4.28 (2.24 - 6.80) | 1999 | Modelled | IHME |
| 4.28 (2.19 - 6.94) | 1998 | Modelled | IHME |
| 4.18 (2.21 - 6.82) | 1997 | Modelled | IHME |
| 4.28 (2.30 - 6.82) | 1996 | Modelled | IHME |
| 4.31 (2.45 - 6.76) | 1995 | Modelled | IHME |
| 4.31 (2.59 - 6.70) | 1994 | Modelled | IHME |
| 4.35 (2.72 - 6.67) | 1993 | Modelled | IHME |
| 4.32 (2.81 - 6.55) | 1992 | Modelled | IHME |
| 4.29 (2.73 - 6.43) | 1991 | Modelled | IHME |
| 4.37 (2.82 - 6.68) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 74 (43 - 113) | 2019 | Modelled | IHME |
| 73 (41 - 111) | 2018 | Modelled | IHME |
| 70 (40 - 106) | 2017 | Modelled | IHME |
| 65 (37 - 99) | 2016 | Modelled | IHME |
| 60 (35 - 93) | 2015 | Modelled | IHME |
| 59 (33 - 91) | 2014 | Modelled | IHME |
| 57 (31 - 91) | 2013 | Modelled | IHME |
| 56 (30 - 89) | 2012 | Modelled | IHME |
| 53 (28 - 86) | 2011 | Modelled | IHME |
| 49 (26 - 81) | 2010 | Modelled | IHME |
| 47 (25 - 77) | 2009 | Modelled | IHME |
| 45 (23 - 73) | 2008 | Modelled | IHME |
| 44 (23 - 72) | 2007 | Modelled | IHME |
| 43 (23 - 69) | 2006 | Modelled | IHME |
| 42 (23 - 68) | 2005 | Modelled | IHME |
| 41 (21 - 66) | 2004 | Modelled | IHME |
| 41 (21 - 65) | 2003 | Modelled | IHME |
| 40 (20 - 65) | 2002 | Modelled | IHME |
| 40 (20 - 64) | 2001 | Modelled | IHME |
| 39 (20 - 63) | 2000 | Modelled | IHME |
| 39 (20 - 61) | 1999 | Modelled | IHME |
| 38 (20 - 62) | 1998 | Modelled | IHME |
| 37 (19 - 60) | 1997 | Modelled | IHME |
| 37 (20 - 59) | 1996 | Modelled | IHME |
| 37 (21 - 58) | 1995 | Modelled | IHME |
| 36 (22 - 57) | 1994 | Modelled | IHME |
| 36 (23 - 56) | 1993 | Modelled | IHME |
| 35 (23 - 54) | 1992 | Modelled | IHME |
| 34 (22 - 52) | 1991 | Modelled | IHME |
| 34 (22 - 52) | 1990 | Modelled | IHME |
| 17 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 27 (18 - 37) | 2019 | Modelled | IHME |
| 27 (18 - 37) | 2018 | Modelled | IHME |
| 27 (18 - 37) | 2017 | Modelled | IHME |
| 27 (18 - 36) | 2016 | Modelled | IHME |
| 26 (18 - 36) | 2015 | Modelled | IHME |
| 26 (18 - 36) | 2014 | Modelled | IHME |
| 26 (18 - 36) | 2013 | Modelled | IHME |
| 26 (18 - 36) | 2012 | Modelled | IHME |
| 26 (18 - 36) | 2011 | Modelled | IHME |
| 27 (18 - 36) | 2010 | Modelled | IHME |
| 26 (18 - 36) | 2009 | Modelled | IHME |
| 26 (18 - 36) | 2008 | Modelled | IHME |
| 26 (18 - 36) | 2007 | Modelled | IHME |
| 26 (17 - 35) | 2006 | Modelled | IHME |
| 25 (17 - 35) | 2005 | Modelled | IHME |
| 25 (17 - 34) | 2004 | Modelled | IHME |
| 25 (16 - 34) | 2003 | Modelled | IHME |
| 25 (16 - 34) | 2002 | Modelled | IHME |
| 24 (16 - 34) | 2001 | Modelled | IHME |
| 24 (16 - 34) | 2000 | Modelled | IHME |
| 24 (16 - 33) | 1999 | Modelled | IHME |
| 24 (16 - 33) | 1998 | Modelled | IHME |
| 24 (16 - 33) | 1997 | Modelled | IHME |
| 23 (15 - 33) | 1996 | Modelled | IHME |
| 23 (15 - 32) | 1995 | Modelled | IHME |
| 23 (15 - 32) | 1994 | Modelled | IHME |
| 23 (15 - 31) | 1993 | Modelled | IHME |
| 23 (15 - 31) | 1992 | Modelled | IHME |
| 23 (15 - 31) | 1991 | Modelled | IHME |
| 23 (15 - 31) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2014 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
2016
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
1.35
(%)
2019, latest modelled
(1.01 - 1.80(%))
IHME
Prevalence PWID
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines